Literature DB >> 6825170

Inhibition of DNA methylation by chemical carcinogens in vitro.

V L Wilson, P A Jones.   

Abstract

A diverse range of ultimate chemical carcinogens inhibited the transfer of methyl groups from S-adenosylmethionine to hemimethylated DNA in a reaction catalyzed by mouse spleen methyltransferase. The formation of alkali-labile sites in DNA lessened its ability to accept methyl groups in vitro, but the methylation reaction was much less sensitive to thymine dimers or double-strand breaks. Carcinogens induced the formation of alkali-labile DNA lesions, but the degree of methyltransferase inhibition observed was greater than that expected for this damage alone. Certain carcinogens were also capable of direct modification and inactivation of the methyltransferase enzyme. Benzo(a)pyrene treatment of living BALB/3T3 A31 clone 1-13 but not C3H/10T1/2 clone 8 cells resulted in a 12% decrease in total 5-methylcytosine content of cellular DNA. Carcinogenic agents may therefore cause heritable changes in 5-methylcytosine patterns in certain cell types by a variety of mechanisms, including adduct formation, induction of apurinic sites and single-strand breaks and direct inactivation of DNA methyltransferase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6825170     DOI: 10.1016/0092-8674(83)90514-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  63 in total

1.  Induced instability of two Arabidopsis constitutive pathogen-response alleles.

Authors:  Trevor L Stokes; Eric J Richards
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  Dnmt3a-CD is less susceptible to bulky benzo[a]pyrene diol epoxide-derived DNA lesions than prokaryotic DNA methyltransferases.

Authors:  Olga V Lukashevich; Vladimir B Baskunov; Maria V Darii; Alexander Kolbanovskiy; Alexander A Baykov; Elizaveta S Gromova
Journal:  Biochemistry       Date:  2011-01-13       Impact factor: 3.162

3.  A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide.

Authors:  Z Ji; L Zhang; V Peng; X Ren; C M McHale; M T Smith
Journal:  Leukemia       Date:  2010-03-25       Impact factor: 11.528

4.  Effects of 5-azacytidine on the progressive nature of cell transformation.

Authors:  W L Hsiao; S Gattoni-Celli; I B Weinstein
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

5.  Concurrent replication and methylation at mammalian origins of replication.

Authors:  F D Araujo; J D Knox; M Szyf; G B Price; M Zannis-Hadjopoulos
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

6.  Stage-specific DNA methylation in a fungal plant pathogen.

Authors:  E R Jupe; J M Magill; C W Magill
Journal:  J Bacteriol       Date:  1986-02       Impact factor: 3.490

7.  Combined effects of prenatal polycyclic aromatic hydrocarbons and material hardship on child IQ.

Authors:  Julia Vishnevetsky; Deliang Tang; Hsin-Wen Chang; Emily L Roen; Ya Wang; Virginia Rauh; Shuang Wang; Rachel L Miller; Julie Herbstman; Frederica P Perera
Journal:  Neurotoxicol Teratol       Date:  2015-04-23       Impact factor: 3.763

8.  Investigating the epigenetic effects of a prototype smoke-derived carcinogen in human cells.

Authors:  Stella Tommasi; Sang-in Kim; Xueyan Zhong; Xiwei Wu; Gerd P Pfeifer; Ahmad Besaratinia
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

9.  Prenatal airborne polycyclic aromatic hydrocarbon exposure and child IQ at age 5 years.

Authors:  Frederica P Perera; Zhigang Li; Robin Whyatt; Lori Hoepner; Shuang Wang; David Camann; Virginia Rauh
Journal:  Pediatrics       Date:  2009-07-20       Impact factor: 7.124

10.  CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity.

Authors:  Benny J Evison; Rebecca A Bilardi; Francis C K Chiu; Gabriella Pezzoni; Don R Phillips; Suzanne M Cutts
Journal:  Nucleic Acids Res       Date:  2009-08-31       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.